BitMEX co-founder pivots to longevity research with major stake in regenerative medicine
Arthur Hayes, co-founder of BitMEX and one of the most influential figures in crypto, is making headlines again—this time for an entirely different reason. Fresh off a presidential pardon by Donald Trump in March, Hayes has turned his attention to longevity and regenerative medicine, taking a board seat and major stake in a stem cell company.
Hayes revealed that he has been a regular patient at the company’s clinics in Mexico and Bangkok for over a year, emphasizing his commitment to health and life extension. “I want to live as long as possible, as healthy as possible,” Hayes said, pointing to the global shift in stem cell therapy regulations that are making advanced treatments more accessible.
The unnamed firm, currently undergoing a rebrand, focuses on cutting-edge regenerative medicine aimed at slowing or reversing the effects of aging. This move aligns with a growing trend among crypto entrepreneurs investing in biotechnology and longevity startups.
Tech Leaders Drive Anti-Aging Revolution
Hayes isn’t alone in this vision. Ethereum creator Vitalik Buterin previously contributed millions to life-extension research, calling aging “a reversible process” that could eventually allow humans to live for centuries. Similarly, Coinbase CEO Brian Armstrong co-founded NewLimit, a biotech startup that raised $130 million to explore epigenetic reprogramming for longevity.
These developments underscore a significant intersection between wealth from digital assets and the future of human health. Industry analysts note that crypto’s high-risk, high-reward culture naturally aligns with bold bets on life sciences.
Still Active in Crypto
While embracing this new frontier, Hayes hasn’t abandoned digital assets. Through his Maelstrom fund, he continues to invest in blockchain projects, Bitcoin grants, and digital asset infrastructure, signaling that his influence spans both financial innovation and human longevity.
As the regulatory environment for stem cell research continues to evolve, experts predict a surge of investment from tech and crypto billionaires seeking to extend not just wealth—but life itself.
Disclaimer
This content is for informational purposes only and does not constitute financial, investment, or legal advice. Cryptocurrency trading involves risk and may result in financial loss.